Skip to main content
Top
Published in: Abdominal Radiology 8/2017

01-08-2017

Contrast-enhanced ultrasound for differentiating benign from malignant solid small renal masses: comparison with contrast-enhanced CT

Authors: Shu-Ping Wei, Chao-Li Xu, Qing Zhang, Qi-Rui Zhang, Yan-E Zhao, Peng-Fei Huang, Ying-Dong Xie, Chang-Sheng Zhou, Fu-Li Tian, Bin Yang

Published in: Abdominal Radiology | Issue 8/2017

Login to get access

Abstract

Purpose

The study aimed to compare the diagnostic efficiency of contrast-enhanced ultrasound (CEUS) with that of contrast-enhanced computed tomography (CECT) in the evaluation of benign and malignant small renal masses (SRMs) (<4 cm) confirmed by pathology.

Methods

A total of 118 patients with 118 renal masses smaller than 4 cm diagnosed by both CEUS and CECT were enrolled in this study, including 25 benign lesions and 93 malignant lesions. All lesions were confirmed by histopathologic diagnosis after surgical resection. The diagnostic imaging studies of the patients were retrospectively reviewed by two independent ultrasonologists and two independent radiologists blinded to the CT or ultrasound findings and final histological results. All lesions on both CEUS and CECT were independently scored on a 3-point scale (1: benign, 2: equivocal, and 3: malignant). The concordance between interobserver agreement was interpreted using a weighted kappa statistic. The diagnostic efficiency of the evaluation of benign and malignant lesions was compared between CEUS and CECT.

Results

All the 118 included lesions were detected by both CEUS and CECT. In CEUS and CECT imaging evaluation of the 118 lesions, the weighted kappa value interpreting the concordance between interobserver agreement was 0.89 (95% CI 0.79–0.98) and 0.93 (95% CI 0.87–0.99), respectively. Both CEUS and CECT demonstrated good diagnostic performance in differential diagnosis of benign and malignant SRMs with sensitivity of 93.5% and 89.2%, specificity of 68% and 76%, PPV of 91.6% and 93.3%, NPV of 73.9% and 65.5%, and AUC of 0.808 and 0.826, respectively. There was no statistically significant difference in any of the diagnostic performance indices between these two methods (P > 0.05). However, the qualitative diagnosis of small papillary renal cell carcinoma (RCC) by CEUS was significantly better than that by CECT (P < 0.05), while there was no significant difference in qualitative diagnostic accuracy on other histotypes of SRMs between CEUS and CECT (P > 0.05).

Conclusions

Both CEUS and CECT imaging modalities are effective for the differential diagnosis of benign and malignant SRMs. Furthermore, CEUS may be more effective than CECT for the qualitative diagnosis of small papillary RCC.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ferlay J, Soerjomataram I, Dikshit R, et al. (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–386. doi:10.1002/ijc.29210 CrossRefPubMed Ferlay J, Soerjomataram I, Dikshit R, et al. (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–386. doi:10.​1002/​ijc.​29210 CrossRefPubMed
9.
go back to reference Sanz Mayayo E, Hevia Palacios V, Arias Funez F, et al. (2012) Bibliographic review about the usefulness of ultrasound contrast media in the study of renal masses. Arch Esp Urol 65(5):556–566PubMed Sanz Mayayo E, Hevia Palacios V, Arias Funez F, et al. (2012) Bibliographic review about the usefulness of ultrasound contrast media in the study of renal masses. Arch Esp Urol 65(5):556–566PubMed
10.
go back to reference Quaia E, Bertolotto M, Cioffi V, et al. (2008) Comparison of contrast-enhanced sonography with unenhanced sonography and contrast-enhanced CT in the diagnosis of malignancy in complex cystic renal masses. AJR Am J Roentgenol 191(4):1239–1249. doi:10.2214/AJR.07.3546 CrossRefPubMed Quaia E, Bertolotto M, Cioffi V, et al. (2008) Comparison of contrast-enhanced sonography with unenhanced sonography and contrast-enhanced CT in the diagnosis of malignancy in complex cystic renal masses. AJR Am J Roentgenol 191(4):1239–1249. doi:10.​2214/​AJR.​07.​3546 CrossRefPubMed
11.
go back to reference Harvey CJ, Alsafi A, Kuzmich S, Ngo A, Papadopoulou I, Lakhani A, Berkowitz Y, Moser S, Sidhu PS, Cosgrove DO (2015) Role of US contrast agents in the assessment of indeterminate solid and cystic lesions in native and transplant kidneys. Radiographics 35(5):1419–1430. doi:10.1148/rg.2015140222 Harvey CJ, Alsafi A, Kuzmich S, Ngo A, Papadopoulou I, Lakhani A, Berkowitz Y, Moser S, Sidhu PS, Cosgrove DO (2015) Role of US contrast agents in the assessment of indeterminate solid and cystic lesions in native and transplant kidneys. Radiographics 35(5):1419–1430. doi:10.​1148/​rg.​2015140222
12.
go back to reference Piscaglia F, Nolsoe C, Dietrich CF, et al. (2012) The EFSUMB Guidelines and Recommendations on the Clinical Practice of Contrast Enhanced Ultrasound (CEUS): update 2011 on non-hepatic applications. Ultraschall Med 33(1):33–59. doi:10.1055/s-0031-1281676 CrossRefPubMed Piscaglia F, Nolsoe C, Dietrich CF, et al. (2012) The EFSUMB Guidelines and Recommendations on the Clinical Practice of Contrast Enhanced Ultrasound (CEUS): update 2011 on non-hepatic applications. Ultraschall Med 33(1):33–59. doi:10.​1055/​s-0031-1281676 CrossRefPubMed
13.
17.
go back to reference Sparchez Z, Radu P, Sparchez M, Crisan N, Kacso G, Petrut B (2015) Contrast enhanced ultrasound of renal masses. A reappraisal of EFSUMB recommendations and possible emerging applications. Med Ultrason 17(2):219–226. Sparchez Z, Radu P, Sparchez M, Crisan N, Kacso G, Petrut B (2015) Contrast enhanced ultrasound of renal masses. A reappraisal of EFSUMB recommendations and possible emerging applications. Med Ultrason 17(2):219–226.
20.
go back to reference Sasaguri K, Takahashi N, Gomez-Cardona D, et al. (2015) Small (<4 cm) renal mass: differentiation of oncocytoma from renal cell carcinoma on biphasic contrast-enhanced CT. AJR Am J Roentgenol 205(5):999–1007. doi:10.2214/AJR.14.13966 CrossRefPubMed Sasaguri K, Takahashi N, Gomez-Cardona D, et al. (2015) Small (<4 cm) renal mass: differentiation of oncocytoma from renal cell carcinoma on biphasic contrast-enhanced CT. AJR Am J Roentgenol 205(5):999–1007. doi:10.​2214/​AJR.​14.​13966 CrossRefPubMed
25.
go back to reference Xu ZF, Xu HX, Xie XY, et al. (2010) Renal cell carcinoma and renal angiomyolipoma: differential diagnosis with real-time contrast-enhanced ultrasonography. J Ultrasound Med 29(5):709–717CrossRefPubMed Xu ZF, Xu HX, Xie XY, et al. (2010) Renal cell carcinoma and renal angiomyolipoma: differential diagnosis with real-time contrast-enhanced ultrasonography. J Ultrasound Med 29(5):709–717CrossRefPubMed
27.
go back to reference Lee-Felker SA, Felker ER, Tan N, et al. (2014) Qualitative and quantitative MDCT features for differentiating clear cell renal cell carcinoma from other solid renal cortical masses. AJR Am J Roentgenol 203(5):W516–524. doi:10.2214/AJR.14.12460 CrossRefPubMed Lee-Felker SA, Felker ER, Tan N, et al. (2014) Qualitative and quantitative MDCT features for differentiating clear cell renal cell carcinoma from other solid renal cortical masses. AJR Am J Roentgenol 203(5):W516–524. doi:10.​2214/​AJR.​14.​12460 CrossRefPubMed
28.
go back to reference Li CX, Lu Q, Huang BJ, et al. (2014) The value of contrast-enhanced ultrasound (CEUS) in detecting minute renal cell carcinoma. Discov Med 18(99):179–188PubMed Li CX, Lu Q, Huang BJ, et al. (2014) The value of contrast-enhanced ultrasound (CEUS) in detecting minute renal cell carcinoma. Discov Med 18(99):179–188PubMed
32.
go back to reference Lu Q, Li CX, Huang BJ, Xue LY, Wang WP (2015) Triphasic and epithelioid minimal fat renal angiomyolipoma and clear cell renal cell carcinoma: qualitative and quantitative CEUS characteristics and distinguishing features. Abdom Imaging 40(2):333–342. doi:10.1007/s00261-014-0221-y CrossRefPubMed Lu Q, Li CX, Huang BJ, Xue LY, Wang WP (2015) Triphasic and epithelioid minimal fat renal angiomyolipoma and clear cell renal cell carcinoma: qualitative and quantitative CEUS characteristics and distinguishing features. Abdom Imaging 40(2):333–342. doi:10.​1007/​s00261-014-0221-y CrossRefPubMed
33.
go back to reference Li X, Liang P, Guo M, et al. (2013) Real-time contrast-enhanced ultrasound in diagnosis of solid renal lesions. Discov Med 16(86):15–25PubMed Li X, Liang P, Guo M, et al. (2013) Real-time contrast-enhanced ultrasound in diagnosis of solid renal lesions. Discov Med 16(86):15–25PubMed
34.
go back to reference Bata P, Gyebnar J, Tarnoki DL, et al. (2013) Clear cell renal cell carcinoma and papillary renal cell carcinoma: differentiation of distinct histological types with multiphase CT. Diagn Interv Radiol 19(5):387–392. doi:10.5152/dir.2013.13068 PubMed Bata P, Gyebnar J, Tarnoki DL, et al. (2013) Clear cell renal cell carcinoma and papillary renal cell carcinoma: differentiation of distinct histological types with multiphase CT. Diagn Interv Radiol 19(5):387–392. doi:10.​5152/​dir.​2013.​13068 PubMed
Metadata
Title
Contrast-enhanced ultrasound for differentiating benign from malignant solid small renal masses: comparison with contrast-enhanced CT
Authors
Shu-Ping Wei
Chao-Li Xu
Qing Zhang
Qi-Rui Zhang
Yan-E Zhao
Peng-Fei Huang
Ying-Dong Xie
Chang-Sheng Zhou
Fu-Li Tian
Bin Yang
Publication date
01-08-2017
Publisher
Springer US
Published in
Abdominal Radiology / Issue 8/2017
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-017-1111-x

Other articles of this Issue 8/2017

Abdominal Radiology 8/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.